Linezolid for the Treatment of Infections: A Review of the Clinical and Cost-Effectiveness [Internet]

Excerpt

The purpose of this report is to examine the comparative clinical effectiveness of linezolid, vancomycin and daptomycin for Methicillin-resistant Staphylococcus aureus (MRSA) infections, the comparative clinical effectiveness of linezolid and daptomycin for the treatment of VRE infections, and the cost-effectiveness of linezolid and daptomycin for MRSA and vancomycin-resistant enterococci (VRE) infections. Additionally, the clinical effectiveness and cost-effectiveness of oral versus intravenous linezolid will be examined.